Comparison Tool
Brand Comparison Table
Compare StartEnhance's two featured GLP-1 pathways side by side on starting price, positioning, and next-step fit without bouncing between commercial pages.
This tool works best when you already know your dominant decision filter but still want the comparison in one clean view. It keeps the choice practical instead of vague.
- See semaglutide and tirzepatide in one table instead of piecing the comparison together manually.
- Switch the recommendation based on affordability, premium intent, or uncertainty.
- Jump from the table into the exact solution page or comparison hub that matches your situation.
These tools are educational decision aids. They help visitors compare paths, model cost, and choose the right next page.
They do not provide medical advice, do not promise approval, and do not replace the independent provider review that happens after the partner intake.
Affordability points toward semaglutide
If your main filter is the lower monthly starting point, the semaglutide page is the cleaner next read before you enter intake.
| Comparison point | Lower-cost path Compounded Semaglutide | Premium path Compounded Tirzepatide |
|---|---|---|
| Current homepage starting price | $133 / month | $166 / month |
| How StartEnhance positions it | Current most affordable StartEnhance homepage offer | Current higher-cost StartEnhance homepage offer |
| Best for | Self-pay visitors prioritizing the lower starting price | Visitors already leaning toward tirzepatide specifically |
| Decision style | Budget-first comparison | Medication-first comparison |
| Workflow fit | Same StartEnhance intake and independent provider review flow | Same StartEnhance intake and independent provider review flow |
| What to pressure-test | Final cost and fit still depend on provider review and add-on fees | Higher spend only makes sense if you already want that path evaluated |
| Next step | Explore semaglutide | Explore tirzepatide |
This table is a StartEnhance path comparison, not a clinical recommendation. Independent providers still determine eligibility, prescribing, and the final program details.
Related Pages
Use this tool, then open the right page
Semaglutide vs Tirzepatide
Read the broader medication comparison hub if you want more context before deciding.
Compounded Semaglutide Access
Open the semaglutide page if the lower-cost route already looks strongest.
Compounded Tirzepatide Access
Open the tirzepatide page if you are already comfortable with the higher spend.
Keep the next step tied to provider review
Once the tool has clarified the decision, the next step is still the same: independent licensed providers review the intake and decide fit, pricing, and prescribing.
StartEnhance is not a medical provider. Eligibility, diagnosis, treatment, prescribing, shipping, and follow-up are handled by independent licensed healthcare providers and pharmacy partners.